2013-10 | Is Isoniazid Treatment For LTBI Safe For RA Patients With TNF Inhibitor Therapy? | 유대현 |
2018-09 | Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy | 유대현 |
2012-06 | Korean Observational Study Network for Arthritis (KORONA): Establishment of a Prospective Multicenter Cohort for Rheumatoid Arthritis in South Korea | 유대현 |
2019-02 | Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 유대현 |
2015-04 | Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients | 유대현 |
2016-04 | Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data | 유대현 |
2013-06 | MEFV gene mutations and their clinical significance in Korean patients with adult-onset Still's disease | 유대현 |
2011-10 | Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-kappa B and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis | 유대현 |
2013-06 | METHOTREXATE DOSE AND OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS | 유대현 |
2013-05 | Mortality factors in idiopathic inflammatory myopathy: focusing on malignancy and interstitial lung disease | 유대현 |
2017-03 | A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis | 유대현 |
2012-09 | Natural Killer T Cell Deficiency in Active Adult-Onset Still's Disease Correlation of Deficiency of Natural Killer T Cells With Dysfunction of Natural Killer Cells | 유대현 |
2011-06 | Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity | 유대현 |
2018-05 | Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil | 유대현 |
2020-11 | A pharmacokinetic evaluation of the rituximab biosimilar CT-P10 in the treatment of rheumatoid arthritis | 유대현 |
2013-06 | A PHASE 3 RANDOMISED CONTROLLED TRIAL TO COMPARE CT-P13 WITH INFLIXIMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 54 WEEK RESULTS FROM THE PLANETRA STUDY | 유대현 |
2016-04 | A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study | 유대현 |
2013-06 | PILOT TRIAL OF TOCILIZUMAB FOR REFRACTORY PATIENTS WITH ADULT ONSET STILL'S DISEASE | 유대현 |
2013-06 | PREDICTOR OF RENAL SURVIVAL IN LUPUS NEPHRITIS IN KOREA | 유대현 |
2016-09 | Prevalence and possible causes of hypouricemia at a tertiary care hospital | 유대현 |